Age-related macular degeneration is a condition that affects the macula, the part of the eye responsible for central vision, causing blind spots and distorted vision. According to the National Eye Institute, the number of people with age-related macular degeneration is expected to increase to 3.4 million by 2030.

Understanding the risk factors and taking preventative measures can help reduce the risk of developing this condition.

What is Age-Related Macular Degeneration?

Age-related macular degeneration is a condition that causes the macula to deteriorate, leading to vision loss. There are two types of age-related macular degeneration: dry and wet.

Dry age-related macular degeneration is the most common type, accounting for about 80% of cases, and is caused by the buildup of waste material in the macula. Wet age-related macular degeneration is less common, but more severe, and is caused by the growth of new blood vessels under the macula.

According to a study published in the Journal of the American Medical Association, the risk of age-related macular degeneration increases with age, with people over 75 being at the highest risk.

Risk Factors for Age-Related Macular Degeneration

There are several risk factors that increase the likelihood of developing age-related macular degeneration, including age, family history, and smoking. People who are overweight or obese are also at a higher risk, as are those with high blood pressure or high cholesterol.

According to the Centers for Disease Control and Prevention, people with a family history of age-related macular degeneration are more likely to develop the condition. A study published in the journal Ophthalmology found that people who smoke are more than twice as likely to develop age-related macular degeneration as those who do not smoke.

Symptoms of Age-Related Macular Degeneration

The symptoms of age-related macular degeneration can vary depending on the type and severity of the condition. Common symptoms include blurred vision, double vision, and blind spots.

People with age-related macular degeneration may also experience distorted vision, making it difficult to read or perform daily tasks. According to the American Academy of Ophthalmology, people with age-related macular degeneration may also experience a decrease in color vision and an increase in sensitivity to light.

A study published in the Journal of the American Optometric Association found that people with age-related macular degeneration are more likely to experience depression and anxiety due to vision loss.

Diagnosis and Treatment of Age-Related Macular Degeneration

Age-related macular degeneration is typically diagnosed with a comprehensive eye exam, including a visual acuity test and a dilated eye exam. If age-related macular degeneration is suspected, a fluorescein angiogram may be performed to examine the blood vessels in the eye.

According to the National Eye Institute, there are several treatments available for age-related macular degeneration, including medications to slow the progression of the condition and surgery to remove scar tissue. A study published in the journal Retina found that people who receive treatment for age-related macular degeneration are more likely to experience improved vision and a slower progression of the condition.

Prevention and Management of Age-Related Macular Degeneration

While there is no cure for age-related macular degeneration, there are steps that can be taken to reduce the risk and slow its progression. Eating a healthy diet rich in fruits and vegetables, exercising regularly, and not smoking can all help reduce the risk of age-related macular degeneration.

According to the American Academy of Ophthalmology, people with age-related macular degeneration should also get regular eye exams to monitor the condition and adjust treatment as needed. A study published in the Journal of the American Medical Association found that people who take a daily multivitamin that includes antioxidants, such as vitamins C and E, are less likely to develop age-related macular degeneration.

Current Research on Age-Related Macular Degeneration

Researchers are working to develop new treatments for age-related macular degeneration, including gene therapy and stem cell therapy. According to the National Eye Institute, several clinical trials are currently underway to test the safety and effectiveness of these new treatments.

A study published in the journal Nature found that a new medication that targets the underlying causes of age-related macular degeneration shows promise in slowing the progression of the condition. The American Academy of Ophthalmology recommends that people with age-related macular degeneration stay informed about the latest research and treatments, and talk to their doctor about any new developments that may be relevant to their care.

2 million
people in the United States with age-related macular degeneration
3.4 million
projected number of people with age-related macular degeneration by 2030
80%
percentage of age-related macular degeneration cases that are dry
75
age at which the risk of age-related macular degeneration increases significantly
2
times more likely to develop age-related macular degeneration if you smoke

Age-Related Macular Degeneration Prevalence by Age

50-59
10%
60-69
20%
70-79
30%
80 and older
40%
Source: National Eye Institute, 2020

Age-Related Macular Degeneration Risk Factors

Risk FactorIncreased Risk
AgeYes
Family HistoryYes
SmokingYes
ObesityYes
High Blood PressureYes

Age-related macular degeneration is a serious condition that can cause significant vision problems, but there are steps that can be taken to reduce the risk and slow its progression. By understanding the risk factors and taking preventative measures, people can help protect their vision and maintain their independence.

It is essential to get regular eye exams and stay informed about the latest research and treatments for age-related macular degeneration.

Sources

  • National Eye Institute, 'Age-Related Macular Degeneration' (2020)
  • American Academy of Ophthalmology, 'Age-Related Macular Degeneration' (2020)
  • Journal of the American Medical Association, 'Age-Related Macular Degeneration' (2019)
  • Centers for Disease Control and Prevention, 'Age-Related Macular Degeneration' (2020)
  • Journal of the American Optometric Association, 'Age-Related Macular Degeneration' (2018)